Methylene Blue Inhibits Cromakalim-Activated K+ Currents in Follicle-Enclosed Oocytes
暂无分享,去创建一个
M. Oz | Keun-Hang Yang | G. Petroianu | D. Lorke | D. Isaev
[1] A. Tinker,et al. ATP-Sensitive Potassium Channels and Their Physiological and Pathophysiological Roles. , 2018, Comprehensive Physiology.
[2] A. M. Mata,et al. Methylene blue activates the PMCA activity and cross-interacts with amyloid β-peptide, blocking Aβ-mediated PMCA inhibition , 2018, Neuropharmacology.
[3] C. Nichols. Adenosine Triphosphate-Sensitive Potassium Currents in Heart Disease and Cardioprotection. , 2016, Cardiac electrophysiology clinics.
[4] Hussein N. Rubaiy. The therapeutic agents that target ATP-sensitive potassium channels , 2016, Acta pharmaceutica.
[5] L. Tretter,et al. Enhanced hydrogen peroxide generation accompanies the beneficial bioenergetic effects of methylene blue in isolated brain mitochondria. , 2014, Free radical biology & medicine.
[6] M. Oz,et al. Methylene blue inhibits the function of α7-nicotinic acetylcholine receptors. , 2012, CNS & neurological disorders drug targets.
[7] T. Shippenberg,et al. Methylene blue inhibits function of the 5‐HT transporter , 2012, British journal of pharmacology.
[8] M. Oz,et al. Cellular and molecular actions of Methylene Blue in the nervous system , 2011, Medicinal research reviews.
[9] D. Lavigne. Vasopressin and Methylene Blue: Alternate Therapies in Vasodilatory Shock , 2010, Seminars in cardiothoracic and vascular anesthesia.
[10] M. Oz,et al. Methylene blue and Alzheimer's disease. , 2009, Biochemical pharmacology.
[11] P. Gillman,et al. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction , 2007, British journal of pharmacology.
[12] T. Shippenberg,et al. The Endogenous Cannabinoid Anandamide Inhibits Cromakalim-Activated K+ Currents in Follicle-Enclosed Xenopus Oocytes , 2007, Journal of Pharmacology and Experimental Therapeutics.
[13] T. Küçükkılınç,et al. Multi-site inhibition of human plasma cholinesterase by cationic phenoxazine and phenothiazine dyes. , 2007, Archives of biochemistry and biophysics.
[14] U. Demirkılıç,et al. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. , 2005, The Annals of thoracic surgery.
[15] J. Wood,et al. Effects of methylene blue on electrical behavior of myenteric neurons , 1985, Experientia.
[16] R. Mannhold. KATP channel openers: Structure‐activity relationships and therapeutic potential , 2004, Medicinal research reviews.
[17] R. Levin,et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. , 2004, The Annals of thoracic surgery.
[18] T. Shippenberg,et al. Cocaine inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[19] W. Rosenblum. ATP-Sensitive Potassium Channels in the Cerebral Circulation , 2003, Stroke.
[20] M. Oz,et al. Direct noncompetitive inhibition of 5-HT(3) receptor-mediated responses by forskolin and steroids. , 2002, Archives of biochemistry and biophysics.
[21] J. Stasch,et al. NO‐ and haem‐independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle , 2002, British journal of pharmacology.
[22] M. Wainwright,et al. Methylene Blue - a Therapeutic Dye for All Seasons? , 2002, Journal of chemotherapy.
[23] M. Oz,et al. Inhibition of cromakalim-activated K+ current by ethanol in follicle-enclosed Xenopus oocytes , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.
[24] F. Reimann,et al. Pharmacological modulation of KATP channels , 2001 .
[25] F. Ashcroft,et al. New windows on the mechanism of action of K(ATP) channel openers. , 2000, Trends in pharmacological sciences.
[26] F. Ashcroft,et al. The antimalarial agent mefloquine inhibits ATP‐sensitive K‐channels , 2000, British journal of pharmacology.
[27] M. Morad,et al. Functional coupling of human L-type Ca2+ channels and angiotensin AT1A receptors coexpressed in xenopus laevis oocytes: involvement of the carboxyl-terminal Ca2+ sensors. , 1998, Molecular pharmacology.
[28] C. Pang,et al. Pressor and vasoconstrictor effects of methylene blue in endotoxaemic rats , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.
[29] M. Sunagawa,et al. ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells. , 1998, American journal of physiology. Cell physiology.
[30] M. Kress,et al. Methylene blue induces ongoing activity in rat cutaneous primary afferents and depolarization of DRG neurons via a photosensitive mechanism , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.
[31] R. Fischmeister,et al. Methylene blue is a muscarinic antagonist in cardiac myocytes. , 1997, Molecular pharmacology.
[32] F. Ashcroft,et al. Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor , 1997, Nature.
[33] Y. Nakaoka,et al. The Photodynamic Action of Methylene Blue on the Ion Channels of Paramecium Causes Cell Damage , 1997, Photochemistry and photobiology.
[34] J. Stockand,et al. Activation by methylene blue of large Ca(2+)-activated K+ channels. , 1996, Biochimica et biophysica acta.
[35] R. Miledi,et al. Ion channels and membrane receptors in follicle-enclosed Xenopus oocytes. , 1996, Ion channels.
[36] P. Nanasi,et al. Effects of methylene blue and ascorbate on transmembrane potential in frog skeletal muscle. , 1995, General pharmacology.
[37] M. Oz,et al. Potentiation of 5-HT3 receptor-mediated responses by protein kinase C activation. , 1995, Neuroreport.
[38] Y. Lee,et al. Methylene blue induces cytotoxicity in human brain tumor cells. , 1995, Cancer letters.
[39] M. Lazdunski,et al. Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells. , 1994, Molecular pharmacology.
[40] U. Quast,et al. Cellular pharmacology of potassium channel openers in vascular smooth muscle. , 1994, Cardiovascular research.
[41] K. Okamoto,et al. Atrial natriuretic factor potentiates glibenclamide-sensitive K+ currents via the activation of receptor guanylate cyclase in follicle-enclosed Xenopus oocytes. , 1994, European journal of pharmacology.
[42] I. Yoneda,et al. Inhibition by SKF 525A and quinacrine of endogenous glibenclamide-sensitive K+ channels in follicle-enclosed Xenopus oocytes. , 1994, European journal of pharmacology.
[43] H. Sakuta. Inhibition by histamine H1 receptor antagonists of endogenous glibenclamide-sensitive K+ channels in follicle-enclosed Xenopus oocytes. , 1994, European journal of pharmacology.
[44] B. Yeğen,et al. Effect of Methylene Blue on Blood Pressure in Rats , 1993 .
[45] G. Edwards,et al. The pharmacology of ATP-sensitive potassium channels. , 1993, Annual review of pharmacology and toxicology.
[46] K. Okamoto,et al. Modification by cGMP of glibenclamide-sensitive K+ currents in Xenopus oocytes. , 1993, Japanese journal of pharmacology.
[47] K. Okamoto,et al. Inactivation of glibenclamide-sensitive K+ channels in Xenopus oocytes by various calmodulin antagonists. , 1992, European journal of pharmacology.
[48] M. Lazdunski,et al. Hormone-regulated K+ channels in follicle-enclosed oocytes are activated by vasorelaxing K+ channel openers and blocked by antidiabetic sulfonylureas. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[49] M. Lazdunski,et al. Chlorpromazine and related phenothiazines inhibit the ATP-sensitive K+ channel. , 1991, European journal of pharmacology.
[50] L. Thuneberg. Methylene blue as a pharmacological probe of intestinal pacemaker activity. , 1990, The American journal of physiology.
[51] T. Sakai. Acetylcholine induces Ca-dependent K currents in rabbit endothelial cells. , 1990, Japanese journal of pharmacology.
[52] K. Sanders,et al. Effects of methylene blue on rhythmic activity and membrane potential in the canine proximal colon. , 1989, The American journal of physiology.
[53] N. Dascal,et al. The use of Xenopus oocytes for the study of ion channels. , 1987, CRC critical reviews in biochemistry.
[54] L. Ignarro,et al. Dissimilarities between methylene blue and cyanide on relaxation and cyclic GMP formation in endothelium-intact intrapulmonary artery caused by nitrogen oxide-containing vasodilators and acetylcholine. , 1986, The Journal of pharmacology and experimental therapeutics.
[55] R. Miledi,et al. Chloride current induced by injection of calcium into Xenopus oocytes. , 1984, The Journal of physiology.
[56] J. Starkus,et al. Kinetic analysis of sodium channel block by internal methylene blue in pronased crayfish giant axons. , 1984, Biophysical journal.
[57] L. Ignarro,et al. Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite. , 1981, Canadian journal of physiology and pharmacology.